Press release -
Oversubscribed private placement - total €10,5 Million (100 MNOK) in ConceptoMed AS
The Board of Directors of ConceptoMed AS announce the final completion of the successful private placement of equity in ConceptoMed AS for the period January-February 2016. The placement round was oversubscribed.
ConceptoMed have been granted CE mark approval for Luer-Jack, launched the product in Europe, and so far announced exclusive distribution agreements for 11 countries in Europe and the Middle East Region.
Gross proceeds from the January-February 2016 private placement rounds amounts to NOK 100 Million (€10,4 Million), whereof approx. NOK 26 Million were subscribed by existing shareholders.
This private placement will finance the global market introduction and further growth.
ConceptoMed is committed to pursue global distribution, and to offer an innovative addition to the traditional medical disposable syringe worldwide. We are now searching for additional eager-to-grow distribution partners worldwide.
ConceptoMed is a rising Medtech star with innovative product categories, unique patent protected Medtech technology and strong finances. We develop and commercialize smart Medtech solutions for an international market. Excellence through Simplicity! We are brave, curious, dedicated and open-minded. Based in Norway, the team is continuously meeting milestones and expanding its activities for International growth.